FDA — authorised 5 May 1970
- Application: NDA050109
- Marketing authorisation holder: PFIZER
- Local brand name: MITHRACIN
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Mithramycin in United States
FDA authorised Mithramycin on 5 May 1970
Marketing authorisation
Other Oncology approved in United States
Frequently asked questions
Is Mithramycin approved in United States?
Yes. FDA authorised it on 5 May 1970.
Who is the marketing authorisation holder for Mithramycin in United States?
PFIZER holds the US marketing authorisation.